Company intelligence / Profile preview

ViroStatics

Sassari, Sardinia, Italyvirostatics.com ↗

Ownership: Private
Employees: ~10
Development stage: Preclinical

Overview

ViroStatics has developed a pipeline of novel host cell kinase inhibitors with unique selectivity profiles for oncology indications such as breast cancer resistant to CDK4/6 inhibitors and mesothelioma. Its lead compound Myrtleciclib demonstrates selective inhibition of CDK9/6/4 with anti-proliferative activity in preclinical models. The company also participates in broad-spectrum antiviral research projects but currently has no active clinical trials registered.

Therapeutic areas: OncologyInfectious Diseases
Modalities: Small molecules (notably kinase inhibitors)Broad-spectrum antivirals
Industry: Biotech

Drug pipeline

3 assets

myrtleciclib

Unknown

2 more assets in the full pipeline.

Request access →

Partnerships

Collaborates on national/international research projects such as PANVIRIDE under Italy’s National Recovery and Resilience Plan; large international network of partners/collaborators mentioned but not named specifically.

Beyond the preview

Go deeper on ViroStatics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ViroStatics.

Explore the full profile